Bristol Myers Squibb (BMY), Takeda Pharmaceuticals (TAK), and Astex Pharmaceuticals are joining a consortium that include AbbVie (ABBV) and Johnson & Johnson (JNJ) to share data for training an AI model meant to assist with drug discovery and development, Sneha S K of Reuters reports. The companies will contribute experimentally determined protein-small molecule structures to train an AI model.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BMY:
- Bristol Myers Squibb call volume above normal and directionally bullish
- White House announces deal with Pfizer for ‘most-favored-nation pricing’
- Trump says other drugmakers to join Pfizer with ‘most favored nation’ prices
- Trump Weekly: President threatens new tariffs, announces TikTok deal
- Trump threatens new tariffs on drugs, kitchen cabinets, trucks: Morning Buzz